June 2022 has been an important month for colorectal research in @BJSurgery, attested by high social media activity on this topic.
It all started with a tweet about a paper on the response to neoadjuvant immunotherapy in patients with mismatch repair-deficient/microsatellite instability colorectal cancer. The tweet had 21 likes and 16 retweets by July 7th, and it can be seen here:
Free in June's BJS: Response after neoadjuvant immunotherapy in mismatch repair-deficient/microsatellite instability-high colorectal cancer https://t.co/zwm3P7YyGm@AmyLightnerMD@bplwijn@des_winter@ksoreide@MalinASund@evanscolorectal@nfmkok@robhinchliffe1@young_bjspic.twitter.com/0MX0HXSoW4' BJS (@BJSurgery) June 6, 2022
On the same day, the @BJSOpen published a systematic review on specimen extraction after colorectal resections. Access the article here. This is the tweet:
#systematicreview of specimen extraction via #NOTES or transabdominal approach.📰19 studies/🧑🤝🧑3432 patients🟰 resection margins, node yield no different⏬analgesia and time to oral intake for NOTES#some4surgery#openaccesshttps://t.co/Zc8ZM6V4fepic.twitter.com/MmJ14tmP2F' BJS Open (@BjsOpen) June 6, 2022
Postoperative complications after colorectal cancer surgery have also attracted significant social media attention.
On June 6th, @martin_rutegard tweeted a paper published in @BJSOpen, which found that two chemokines (CXCL6 and CCL11) might predict leakage in rectal cancer. The paper is open access and can be read here. This is the tweet:
Glad to see this paper on preoperative inflammation and anastomotic leak out in @BjsOpen. We found that two chemokines (CXCL6 and CCL11) might predict leakage in rectal cancer, though validation is required. @MalinASund@UmeaUniversityhttps://t.co/XGoFG6nyS7' Martin Rutegard (@martin_rutegard) June 6, 2022
The day after, @BJSurgery posted a tweet about the core outcome set for clinical studies of postoperative ileus after intestinal surgery. This is a frequent postoperative complication that still puzzles us. You can read about it here.
The tweet had had 16 retweets and 23 likes by July 7th:
Free to access June's issue of BJS: Core outcome set for clinical studies of postoperative ileus after intestinal surgery https://t.co/IQhXOXt6YZ@AmyLightnerMD@bplwijn@des_winter@ksoreide@MalinASund@evanscolorectal@nfmkok@robhinchliffe1@young_bjspic.twitter.com/hOK8wNo0NB' BJS (@BJSurgery) June 7, 2022
Anything related to intraperitoneal drains always attracts lots of attention. On June the 9th, @BJSOpen shared another paper with predictor factors of anastomotic leakage, but now found in the abdominal drain on postoperative day 3. The article can be accessed here. This is the tweet:
#anastomoticleakage is a challenge for #colorectalsurgery – can we predict it?Preop serum CXCL6 and CCL11 associated with leak after #rectalcancerhs-CRP after #coloncancer#some4surgery@asgbi@SEIQuirurgica@LauraLorenzonMD@Mcfark@villesallinenhttps://t.co/OqYxA08ZK3pic.twitter.com/AxsJTKCPhj' BJS Open (@BjsOpen) June 8, 2022
However, drains seem to not be associated with earlier detection of postoperative collections, as shown in an open access paper tweeted by @BJSurgery. You can read more here. This was a very popular tweet. It had 25 likes and 17 retweets by July 7th:
Open Access in June's BJS: Intraperitoneal drain placement and outcomes after elective colorectal surgery https://t.co/hkY1zXSBEu@AmyLightnerMD@bplwijn@des_winter@ksoreide@MalinASund@evanscolorectal@nfmkok@robhinchliffe1@young_bjspic.twitter.com/UF4sJmEM3t' BJS (@BJSurgery) June 11, 2022
June was also a memorable month for the BJS community because after two previous cancellations in June 2020 and June 2021, Madrid received the BJS Society Council meeting and General Assembly amidst a heat wave. And social media echoed the joy.
Rebecca Grossman @rebgross and Laura Lorenzon @LauraLorenzonMD kept us updated:
So happy to be here in beautiful Madrid for the first in-person @BJSurgery Council meeting in a long time! #SoMe4Surgery@BJSAcademy@young_bjspic.twitter.com/tRkU0vla1N' Rebecca C Grossman (@rebgross) June 10, 2022
@BJSurgery@BJSOpen@BJSAcademy#council@Madrid ready to start @juliomayol@rebgross@wannabehawkeye@villesallinen@MalinASund@ksoreide@des_winterpic.twitter.com/wdipI4VFXu' Laura Lorenzon (@LauraLorenzonMD) June 10, 2022
We were also very happy because the @BJSAcademy reached 1000 followers by June 21st:
Thank you to our 1000 followers!Recently launched in May 2022, #BJSAcademy is committed to leading lifelong surgical learning through⭐️Cutting-edge reviews⭐️Educational modules⭐️Tutorials, blogs & digests⭐️#MyNightOnCall⭐️Videos & moreJoin us🔗https://t.co/QNd3tAFoUjpic.twitter.com/yto1jehKI9' BJS Academy (@BJSAcademy) June 21, 2022
One more achievement for @BJSAcademy: @jcalverdy opens the Surgical Science section with a post on microbiome and surgery:
*⃣ NEW POST *⃣ #Microbiome & surgery: breakthrough or hype?Drs @JCAlverdy & Benjamin Shogan discuss:"The data output of a typical microbiome analysis can be vast, and determining what is signal versus noise has become problematic."READ full article ⬇️https://t.co/ipVvEwtZn9' BJS Academy (@BJSAcademy) June 24, 2022
This is an open-access post on the BJS Academy website https://www.bjsacademy.com/the-microbiome-and-surgery-breakthrough-or-just-hype
By the end of the month, the appendix gained attention at @BJSurgery and @BjsOpen.
On the 23rd, results of the APPAC III were published: an RCT on uncomplicated diverticulitis. You can learn more here:
In June's BJS: Antibiotics versus placebo in adults with CT-confirmed uncomplicated acute appendicitis (APPAC III) https://t.co/JXlog2CoC7@AmyLightnerMD@bplwijn@des_winter@ksoreide@MalinASund@evanscolorectal@nfmkok@robhinchliffe1@young_bjspic.twitter.com/S0kqvAHaOD' BJS (@BJSurgery) June 23, 2022
Then, on June 25th, an overview of appendix tumors focused on pathology and management is published and available here.
The tweet had 28 likes and 21 retweets by July 7th:
Free to access in July's BJS: ‘It’s not just a mucocoele’—pathology and treatment of appendix tumours https://t.co/qMKJ0OfOpT@AmyLightnerMD@bplwijn@des_winter@ksoreide@MalinASund@evanscolorectal@nfmkok@robhinchliffe1@young_bjspic.twitter.com/PlLlSapoTf' BJS (@BJSurgery) June 25, 2022
Last, but not least, the Journal of Citation Reports announced the 2-year impact factors of scientific journals in late June 2022. The good news brought joy to both @BJSurgery and @BJSOpen editorial boards.
On Instagram, @BJSurgery proudly announced that, for the first time, its impact factor had gone well over 10 to an amazing 11.112. This is a spectacular achievement.
You can read the post here.
The same happened on Twitter on June 28th:
📢 We are delighted to announce the BJS Impact Factor has gone up to 11.122!🌟 We sincerely thank all authors who have entrusted us with their outstanding work.🧐 And we could do nothing without the enduring help and support of our incredible reviewers. Thank you!' BJS (@BJSurgery) June 28, 2022
In addition, the @BJSOpen impact factor went up to 3.875 and led the journal into the first quartile of surgical journals. BJSOpen editor @LauraLorenzonMD tweeted about it. Her tweet had had 45 likes and 16 retweets by July 7th, 2022:
What a day for @BjsOpen! IF increased to 3.875, now officially ranking a Q1 journal. Thks to all the authors who trusted us with their research! Ad majora semper! And guess what happened to @BJSurgery…..?@BJSAcademypic.twitter.com/aDxJoxBgFg' Laura Lorenzon (@LauraLorenzonMD) June 28, 2022
.png)
.jpg){kind=logo}
